EDUCATION

Faculty members in the infectious diseases division provide medical students, internal medicine house staff and ID fellows with the opportunity to obtain information on basic microbiology, diagnostic bacteriology and virology, appropriate use of antimicrobial agents, host factors important to pathogenesis of infection, clinical diagnosis and management of infectious illness, including HIV, and infection control procedures in the prevention of nosocomial infections. Regular student/house staff/fellow conferences (see above) are conducted to provide the medical students, internal medicine residents and ID fellows the opportunity to acquire the principles of diagnosis and management of infectious diseases.
A busy consultative service has been established at Memorial Hermann Hospital-Texas Medical Center where a fellow in infectious diseases, two medical residents and two fourth-year medical students make up a team under the direction of one of the faculty members. Faculty are also active in teaching at LBJ hospital, Thomas Street Clinic (HIV care), UT Professional Building (outpatient ID) and the West Loop Clinic (travel medicine). Our colleagues at MD Anderson Cancer Center have three consultative teaching services: Hematology, Solid Tumors, and ICU.
Division of Infectious Diseases faculty have frequently been awarded the Dean’s Teaching Award for teaching excellence.

RESEARCH

Faculty of the Division of Infectious Diseases conduct a wide range of well funded research. The Division also has strong collaborative relationships with colleagues in other schools and departments that bring together multi-disciplinary research teams to investigate the problems of infectious diseases. One of the cross collaborative efforts is the Center for the Study of Emerging and Re-emerging Pathogens which includes faculty in the Department of Micro and Molecular Genetics, Department of Pathology, and the Department of Pediatrics. Another collaborative effort brings together faculty of both UT and Baylor Medical Schools and the UT School of Public Health. Basic and clinical research in the division includes studies of the mechanisms and molecular epidemiology of antimicrobial resistance, fungal diseases, bacterial pathogenesis, diarrheal diseases including cryptosporidium, pharmacokinetics, and HIV/AIDS. Funding sources for this research include NIH, pharmaceutical companies and other grants. Colleagues at MD Anderson Cancer Center are likewise well funded and productive in research (see website for details).
Infectious Disease Fellows are encouraged to pick a research mentor early in their fellowship. Fellows are expected to complete a project during their first year in time to submit an abstract to either the annual meeting of the Infectious Disease Society of America or the Interscience Conference on Antimicrobial Agents and Chemotherapy. Fellows abstracts are frequently accepted for presentation and travel grants are commonly awarded.

Past Fellow Graduates:

Graduation Year 2007
Danny Ghannam, Kevin Grimes, Andrea Holmes, Roshan Lewis, Harrys Torres, Souad Yousseff

Graduation Year 2006
Halim Aboufaycal, Cesar Arias, Mona Kapadia, Ghazi Ghanem, Charles Sims

Graduation Year 2005
Stephanie Lee, Lisa Armitige, Shoaib Ansari, Gabriel Aisenberg, Padma Kumashi, Mallika Kamana, Samuel Maghidman*

Graduation Year 2004
Annie Philip, Norio Ohmagari, Obiageli Objiofor, Essam Girgaway, Sebastian Fernandez-Bussy*, Owen McCormack*

Graduation Year 2003
Indra De, Roberto Andrade, Martin Montes, Esteban Nannini

Graduation Year 2002
Octavia Cieza*, Guy DeLeRosa, Rosa Infante, Alberto La Rosa, Madonna Matar, Maria Nguyen, Luis Ostrosky-Zeichner, Elphida Paphitou

Graduation Year 2001
Joseph Goodly*, Edgardo Li-Espino*, Julio Marcolini, Zakir Shaikh

Graduation Year 2000
Javier, Adachi, Claude Afif, H. Gomi, K. Malathum, I. Vaziri

Publications of Infectious Disease fellows, who graduated in 2000 or later:

1. Adachi, J. A., C. D. Ericsson, Z. D. Jiang, M. W. DuPont, F. Martinez-Sandoval, C. Knirsch, and H. L. DuPont. 2003. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 37:1165-71.
2. Adachi, J. A., C. D. Ericsson, Z. D. Jiang, M. W. DuPont, S. R. Pallegar, and H. L. DuPont. 2002. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis 185:1681-3.
3. Adachi, J. A., Z. Jiang, M. Cox, L. Wood, H. L. DuPont, and J. J. Mathewson. 2000. Serum antibody response induced in mice after oral administration of three different antigens of enterotoxigenic Escherichia coli in enteric coated microparticles. J Travel Med 7:304-8.
4. Adachi, J. A., Z. D. Jiang, J. J. Mathewson, M. P. Verenkar, S. Thompson, F. Martinez-Sandoval, R. Steffen, C. D. Ericsson, and H. L. DuPont. 2001. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 32:1706-9.
5. Adachi, J. A., J. J. Mathewson, Z. D. Jiang, C. D. Ericsson, and H. L. DuPont. 2002. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med 136:884-7.
6. Adachi, J. A., L. Ostrosky-Zeichner, H. L. DuPont, and C. D. Ericsson. 2000. Empirical antimicrobial therapy for traveler's diarrhea. Clin Infect Dis 31:1079-83.
7. Aisenberg, G., K. V. Rolston, and A. Safdar. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 101:2134-40.
8. Ambur, O. H., P. E. Reynolds, and C. A. Arias. 2002. D-Ala:D-Ala ligase gene flanking the vanC cluster: evidence for presence of three ligase genes in vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 46:95-100.
9. Arias, C. A. 2005. Step 3. In Briscoe D.A. (ed.), In Lange Q&A USMLE, McGraw Hill, New York.
10. Arias, C. A., P. Courvalin, and P. E. Reynolds. 2000. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 44:1660-6.
11. Arias, C. A., and B. E. Murray. 2004. Mechanisms of antibiotic resistance in enterococci. - I and II. In UpToDate, Rose B.D. (ed.), Wellesley, MA.
12. Arias, C. A., D. Panesso, and M. Zuniga. 2003. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation]. Biomedica 23:134-40.
13. Arias, C. A., J. Pena, D. Panesso, and P. Reynolds. 2003. Role of the transmembrane domain of the VanT serine racemase in resistance to vancomycin in Enterococcus gallinarum BM4174. J Antimicrob Chemother 51:557-64.
14. Arias, C. A., G. Quintero, B. E. Vanegas, C. L. Rico, and J. F. Patino. 2003. Surveillance of surgical site infections: decade of experience at a Colombian tertiary care center. World J Surg 27:529-33.
15. Arias, C. A., J. Reyes, M. Zuniga, L. Cortes, C. Cruz, C. L. Rico, and D. Panesso. 2003. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 51:59-68.
16. Arias, C. A., J. Weisner, J. M. Blackburn, and P. E. Reynolds. 2000. Serine and alanine racemase activities of VanT: a protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174. Microbiology 146 ( Pt 7):1727-34.
17. Arikan, S., L. Ostrosky-Zeichner, M. Lozano-Chiu, V. Paetznick, D. Gordon, T. Wallace, and J. H. Rex. 2002. In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates. J Clin Microbiol 40:1406-12.
18. Armitige, L. Y., C. Jagannath, A. R. Wanger, and S. J. Norris. 2000. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun 68:767-78.
19. Bouckenooghe, A. R., H. L. Dupont, Z. D. Jiang, J. Adachi, J. J. Mathewson, M. P. Verenkar, S. Rodrigues, and R. Steffen. 2000. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg 62:711-3.
20. Chemaly, R. F., H. A. Torres, R. Y. Hachem, G. M. Nogueras, E. A. Aguilera, A. Younes, M. A. Luna, G. Rodriguez, J. J. Tarrand, and Raad, II. 2005. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104:1213-20.
21. Copenhaver, R. H., E. Sepulveda, L. Y. Armitige, J. K. Actor, A. Wanger, S. J. Norris, R. L. Hunter, and C. Jagannath. 2004. A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infect Immun 72:7084-95.
22. Cruz, C., J. Moreno, A. Renzoni, M. Hidalgo, J. Reyes, J. Schrenzel, D. Lew, E. Castaneda, and C. A. Arias. 2005. Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996-2003): emergence of a new dominant clone. Int J Antimicrob Agents.
23. De La Rosa, G. R., B. J. Barnett, C. D. Ericsson, and J. B. Turk. 2001. Native valve endocarditis due to Bartonella henselae in a middle-aged human immunodeficiency virus-negative woman. J Clin Microbiol 39:3417-9.
24. De La Rosa, G. R., R. E. Champlin, and D. P. Kontoyiannis. 2002. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis 4:3-9.
25. De la Rosa, G. R., A. Kuliev, and B. J. Barnett. 2002. A case of Strongyloides stercoralis and mesenteric tuberculous infection with acute abdominal pain in an HIV-positive patient. Scand J Infect Dis 34:696-7.
26. Duh, R. W., K. V. Singh, K. Malathum, and B. E. Murray. 2001. In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Microb Drug Resist 7:39-46.
27. DuPont, H. L., Z. D. Jiang, C. D. Ericsson, J. A. Adachi, J. J. Mathewson, M. W. DuPont, E. Palazzini, L. M. Riopel, D. Ashley, and F. Martinez-Sandoval. 2001. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 33:1807-15.
28. Estrada-Garcia, M. T., Z. D. Jiang, J. Adachi, J. J. Mathewson, and H. L. DuPont. 2002. Intestinal immunoglobulin a response to naturally acquired enterotoxigenic Escherichia coli in US travelers to an endemic area of Mexico. J Travel Med 9:247-50.
29. Gomez, J. M., R. Fajardo, J. F. Patino, and C. A. Arias. 2003. Necrotizing fasciitis due to Vibrio alginolyticus in an immunocompetent patient. J Clin Microbiol 41:3427-9.
30. Gomi, H., Z. D. Jiang, J. A. Adachi, D. Ashley, B. Lowe, M. P. Verenkar, R. Steffen, and H. L. DuPont. 2001. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 45:212-6.
31. Hidalgo, M., E. Castaneda, and C. A. Arias. 2003. Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae. J Antimicrob Chemother 52:300-2.
32. Huang, D. B., Z. D. Jiang, C. D. Ericsson, J. Adachi, and H. L. Dupont. 2001. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico. Scand J Infect Dis 33:812-4.
33. Kamana, M., C. Escalante, C. A. Mullen, S. Frisbee-Hume, and K. V. Rolston. 2005. Bacterial infections in low-risk, febrile neutropenic patients. Cancer 104:422-6.
34. Khater, F. J., S. Youssef, S. B. Iskandar, J. W. Myers, and J. P. Moorman. 2004. Lactic acidosis during nucleoside antiretroviral HIV therapy. South Med J 97:208.
35. Kontoyiannis, D. P., G. P. Bodey, H. Hanna, R. Hachem, M. Boktour, E. Girgaway, M. Mardani, and Raad, II. 2004. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma 45:139-41.
36. Kontoyiannis, D. P., M. Boktour, H. Hanna, H. A. Torres, R. Hachem, and Raad, II. 2005. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103:2334-7.
37. Kontoyiannis, D. P., I. Vaziri, H. A. Hanna, M. Boktour, J. Thornby, R. Hachem, G. P. Bodey, and Raad, II. 2001. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33:1676-81.
38. Kumashi, P., E. Girgawy, J. J. Tarrand, K. V. Rolston, Raad, II, and A. Safdar. 2005. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 84:303-12.
39. Lawrence, E. R., C. A. Arias, B. Duke, D. Beste, K. Broughton, A. Efstratiou, R. C. George, and L. M. Hall. 2000. Evaluation of serotype prediction by cpsA-cpsB gene polymorphism in Streptococcus pneumoniae. J Clin Microbiol 38:1319-23.
40. Lee, S. A., A. H. Diwan, M. Cohn, R. Champlin, and A. Safdar. 2005. Cutaneous toxoplasmosis: a case of confounding diagnosis. Bone Marrow Transplant 36:465-6.
41. Lee, S. A., Raad, II, J. A. Adachi, and X. Y. Han. 2004. Catheter-related bloodstream infection caused by Mycobacterium brumae. J Clin Microbiol 42:5429-31.
42. Lionakis, M. S., R. E. Lewis, H. A. Torres, N. D. Albert, Raad, II, and D. P. Kontoyiannis. 2005. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52:15-20.
43. Malathum, K., T. M. Coque, K. V. Singh, and B. E. Murray. 1999. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob Agents Chemother 43:930-6.
44. Malathum, K., and B. E. Murray. 1999. Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options. Drug Resist Updates 2:224-243.
45. Malathum, K., K. V. Singh, and B. E. Murray. 1999. In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria. Diagn Microbiol Infect Dis 35:127-33.
46. Malathum, K., K. V. Singh, G. M. Weinstock, and B. E. Murray. 1998. Repetitive sequence-based PCR versus pulsed-field gel electrophoresis for typing of Enterococcus faecalis at the subspecies level. J Clin Microbiol 36:211-5.
47. Marcolini, J., M. Nguyen, and C. Ericsson. 2002. Klebsiella pneumoniae brain abscess in a Taiwanese adult. J Infect 44:205-10.
48. Marcolini, J. A., S. Malik, D. Suki, E. Whimbey, and G. P. Bodey. 2003. Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis 22:79-84.
49. Matar, M. J., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2003. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 47:1647-51.
50. Nannini, E. C., X. Han, W. A. O'Brien, and R. C. Arduino. 2002. Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas. J Acquir Immune Defic Syndr 29:317-9.
51. Nannini, E. C., M. Keating, P. Binstock, G. Samonis, and D. P. Kontoyiannis. 2002. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect 44:201-3.
52. Nannini, E. C., and B. E. Murray. 2004. Enterococcus. In Principles and Practice of Clinical Bacteriology. Hawkey P, Gillespie S. eds. John Wiley & Sons, Ltd., Sussex, England.
53. Nannini, E. C., and B. E. Murray. 2004. Glycopeptides: Vancomycin and Teicoplanin, Lipopeptides: Daptomycin, and Streptogramins: Quinupristin/Dalfopristin. In Principles and Practice of Infectious Diseases (6th edition). Editors: GL Mandell, MD, JE Bennett, MD, and R Dolin, MD, Elsevier Inc.
54. Nannini, E. C., and B. E. Murray. 2003. Vancomycin-resistant enterococci. In Re-emergence of Established Pathogens in the 21st Century. Fong I.W., Drlica K. eds.:155-204.
55. Nannini, E. C., and P. C. Okhuysen. 2002. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep 4:392-8.
56. Nannini, E. C., S. R. Pai, K. V. Singh, and B. E. Murray. 2003. Activity of tigecycline (GAR-936), a novel glycylcycline, against enterococci in the mouse peritonitis model. Antimicrob Agents Chemother 47:529-32.
57. Nannini, E. C., N. I. Paphitou, and L. Ostrosky-Zeichner. 2003. Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature. Diagn Microbiol Infect Dis 46:49-54.
58. Nannini, E. C., K. V. Singh, and B. E. Murray. 2003. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 37:1194-8.
59. Nannini, E. C., F. Teng, K. V. Singh, and B. E. Murray. 2005. Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis model. Infect Immun 73:7772-4.
60. Ohmagari, N., Raad, II, R. Hachem, and D. P. Kontoyiannis. 2004. Invasive aspergillosis in patients with solid tumors. Cancer 101:2300-2.
61. Okhuysen, P. C., S. M. Rich, C. L. Chappell, K. A. Grimes, G. Widmer, X. Feng, and S. Tzipori. 2002. Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. J Infect Dis 185:1320-5.
62. Ostrosky-Zeichner, L., S. Bazemore, V. L. Paetznick, J. R. Rodriguez, E. Chen, T. Wallace, P. Cossum, and J. H. Rex. 2001. Differential antifungal activity of isomeric forms of nystatin. Antimicrob Agents Chemother 45:2781-6.
63. Ostrosky-Zeichner, L., J. H. Rex, J. Bennett, and B. J. Kullberg. 2002. Deeply invasive candidiasis. Infect Dis Clin North Am 16:821-35.
64. Panesso, D., L. Abadia-Patino, N. Vanegas, P. E. Reynolds, P. Courvalin, and C. A. Arias. 2005. Transcriptional analysis of the vanC cluster from Enterococcus gallinarum strains with constitutive and inducible vancomycin resistance. Antimicrob Agents Chemother 49:1060-6.
65. Panesso, D., S. Ospina, J. Robledo, M. C. Vela, J. Pena, O. Hernandez, J. Reyes, and C. A. Arias. 2002. First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. Emerg Infect Dis 8:961-5.
66. Paphitou, N. I., and B. J. Barnett. 2002. Solitary parietal lobe histoplasmoma mimicking a brain tumor. Scand J Infect Dis 34:229-32.
67. Paphitou, N. I., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2002. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 46:3298-300.
68. Paphitou, N. I., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2002. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 46:1144-6.
69. Pham, A. S., I. De, K. V. Rolston, J. J. Tarrand, and X. Y. Han. 2003. Catheter-related bacteremia caused by the nocardioform actinomycete Gordonia terrae. Clin Infect Dis 36:524-7.
70. Philip, A., Z. Odabasi, G. Matiuzzi, V. L. Paetznick, S. W. Tan, J. Warmington, J. H. Rex, and L. Ostrosky-Zeichner. 2005. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J Clin Microbiol 43:4834-5.
71. Philip, A., Z. Odabasi, J. Rodriguez, V. L. Paetznick, E. Chen, J. H. Rex, and L. Ostrosky-Zeichner. 2005. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother 49:3572-4.
72. Picolos, M. K., C. R. Sims, J. M. Mastrobattista, M. A. Carroll, and V. R. Lavis. 2004. Milk-alkali syndrome in pregnancy. Obstet Gynecol 104:1201-4.
73. Puech, V., C. Guilhot, E. Perez, M. Tropis, L. Y. Armitige, B. Gicquel, and M. Daffe. 2002. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Mol Microbiol 44:1109-22.
74. Raad, II, C. Escalante, R. Y. Hachem, H. A. Hanna, R. Husni, C. Afif, M. R. Boktour, E. E. Whimbey, D. Kontoyiannis, K. Jacobson, H. Kantarjian, L. M. Levett, and K. V. Rolston. 2003. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer 98:1039-47.
75. Ripeau, J. S., F. Aumont, P. Belhumeur, L. Ostrosky-Zeichner, J. H. Rex, and L. de Repentigny. 2002. Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro. Antimicrob Agents Chemother 46:3096-100.
76. Rolston, K. V., I. Vaziri, S. Frisbee-Hume, H. Streeter, and B. LeBlanc. 2004. In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients. Chemotherapy 50:214-20.
77. Safdar, A., K. Malathum, S. J. Rodriguez, R. Husni, and K. V. Rolston. 2004. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 100:1531-6.
78. Safdar, A., G. Rodriguez, N. Ohmagari, D. P. Kontoyiannis, K. V. Rolston, Raad, II, and R. E. Champlin. 2005. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 103:731-9.
79. Scerpella, E. G., A. R. Wanger, L. Armitige, P. Anderlini, and C. D. Ericsson. 1995. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 16:92-7.
80. Shaikh, Z. H., C. A. Osting, H. A. Hanna, R. B. Arbuckle, J. J. Tarr, and Raad, II. 2002. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 51:52-8.
81. Shaikh, Z. H., C. A. Peloquin, and C. D. Ericsson. 2001. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 33:375-9.
82. Shaikh, Z. H., N. T. Ueno, and D. P. Kontoyiannis. 2001. Fatal Salmonella group G enteritis mimicking intestinal graft-versus-host disease in a bone marrow transplant recipient. Transpl Infect Dis 3:29-33.
83. Sims, C. R., L. Ostrosky-Zeichner, and J. H. Rex. 2005. Invasive candidiasis in immunocompromised hospitalized patients. Arch Med Res 36:660-71.
84. Singh, K. V., K. Malathum, and B. E. Murray. 2001. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother 45:263-6.
85. Singh, K. V., S. R. Nallapareddy, E. C. Nannini, and B. E. Murray. 2005. Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect Immun 73:4888-94.
86. Smith, K. C., L. Armitige, and A. Wanger. 2003. A review of tuberculosis: reflections on the past, present and future of a global epidemic disease. Expert Rev Anti Infect Ther 1:483-91.
87. Sutjita, M., A. R. Bouckenooghe, J. A. Adachi, Z. D. Jiang, J. J. Mathewson, C. D. Ericsson, and H. L. DuPont. 2000. Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea. Clin Diagn Lab Immunol 7:501-3.
88. Torres, H. A., D. P. Kontoyiannis, G. P. Bodey, J. A. Adachi, M. A. Luna, J. J. Tarrand, G. M. Nogueras, Raad, II, and R. F. Chemaly. 2005. Gastrointestinal cytomegalovirus disease in patients with cancer: A two decade experience in a tertiary care cancer center. Eur J Cancer 41:2268-79.
89. Torres, H. A., V. G. Prieto, Raad, II, and D. P. Kontoyiannis. 2005. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact C. neoformans. Mycoses 48:21-4.
90. Youssef, S. S., and P. P. Kumar. 2004. Jaundice secondary to isolated porta hepatis metastasis in colorectal cancer: case report and review of the literature. South Med J 97:287-90.
91. Infante RM, , Ericsson CD, Jiang Z-D, Ke S, Steffen R, Riopel L, Sack DA, DuPont HL. Enteroaggregative Escherichia coli (EAEC) Diarrhea in Travelers: Response to Rifaximin Therapy. Clin Gastroenterol Hepatology 2004; 2:135-8.
92. Gomi H, Jiang Z-D, Adachi JA, Ashley D, Lowe B, Verenkar MP, Steffen R, DuPont HL. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 2001; 45:212-16.